awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33884913-201DA851-F948-476A-9DF8-EBE0F833340D
Q33884913-201DA851-F948-476A-9DF8-EBE0F833340D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33884913-201DA851-F948-476A-9DF8-EBE0F833340D
Exenatide once weekly treatment maintained improvements in glycemic control and weight loss over 2 years.
P2860
Q33884913-201DA851-F948-476A-9DF8-EBE0F833340D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33884913-201DA851-F948-476A-9DF8-EBE0F833340D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e3fdb9964f7e3edcdd54e116979b7bab912b7ebe
P2860
Pharmacology of exenatide (synthetic exendin-4): a potential therapeutic for improved glycemic control of type 2 diabetes.